{"recordsFiltered":49668,"recordsTotal":49668,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-registry_id&start=42000","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-registry_id&start=41400","results":[{"registry_id":"NCT05564091","publication_url":"https://clinicaltrials.gov/study/NCT05564091","title":"Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma","has_exemption":false,"start_date":"2022-09-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Nova Eye, Inc.","sponsor_slug":"nova-eye-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05543694","publication_url":"https://clinicaltrials.gov/study/NCT05543694","title":"ED90 of Epidural Bupivacaine for the Initiation of Labor Analgesia: A Randomized Biased Coin Sequential Allocation Trial With a Lidocaine Test Dose","has_exemption":false,"start_date":"2022-10-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05381597","publication_url":"https://clinicaltrials.gov/study/NCT05381597","title":"Combination of 5-Fluorouracil and Calcipotriene in the Treatment of Superficial Basal Cell Carcinomas and Squamous Cell Carcinomas in Situ","has_exemption":false,"start_date":"2022-10-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Boston University","sponsor_slug":"boston-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06128720","publication_url":"https://clinicaltrials.gov/study/NCT06128720","title":"A Randomized, Sham Controlled, Masked Phase II Study to Evaluate the Neuroprotective Effect of Hyperbaric Oxygen Therapy on Optic Neuropathy","has_exemption":false,"start_date":"2022-11-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05518903","publication_url":"https://clinicaltrials.gov/study/NCT05518903","title":"Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)","has_exemption":false,"start_date":"2022-11-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05641688","publication_url":"https://clinicaltrials.gov/study/NCT05641688","title":"An Open-label, Non-randomized, Multi-center Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of PET Imaging With [18F]PI-2620 for the Detection of Tau Deposition When Compared to Post-mortem Histopathology (ADvance)","has_exemption":false,"start_date":"2022-12-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Lantheus Biosciences Ltd.","sponsor_slug":"lantheus-biosciences-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05633654","publication_url":"https://clinicaltrials.gov/study/NCT05633654","title":"A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy","has_exemption":false,"start_date":"2022-12-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05198830","publication_url":"https://clinicaltrials.gov/study/NCT05198830","title":"A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination With Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2022-12-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05499702","publication_url":"https://clinicaltrials.gov/study/NCT05499702","title":"The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction","has_exemption":false,"start_date":"2022-12-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Adrian Vella","sponsor_slug":"adrian-vella","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05674825","publication_url":"https://clinicaltrials.gov/study/NCT05674825","title":"An Open-label, Navigational Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses","has_exemption":false,"start_date":"2022-12-21","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05396105","publication_url":"https://clinicaltrials.gov/study/NCT05396105","title":"A Phase II/III, Extension Study of Orally Administered PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema","has_exemption":false,"start_date":"2022-12-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Pharvaris Netherlands B.V.","sponsor_slug":"pharvaris-netherlands-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05442034","publication_url":"https://clinicaltrials.gov/study/NCT05442034","title":"Rh-PDGF Versus Emdogain for Treatment of Intra-bony Defects","has_exemption":false,"start_date":"2023-01-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Nova Southeastern University","sponsor_slug":"nova-southeastern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05386342","publication_url":"https://clinicaltrials.gov/study/NCT05386342","title":"A Post-market Clinical Study to Confirm the Performance and Safety of the LeMaitre TufTex Over-the-Wire (OTW) Embolectomy Catheter on Patients Undergoing Surgical Treatment for the Removal of Arterial Emboli and/or Thrombi","has_exemption":false,"start_date":"2023-01-11","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"LeMaitre Vascular","sponsor_slug":"lemaitre-vascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05586776","publication_url":"https://clinicaltrials.gov/study/NCT05586776","title":"Decolonization to Reduce After-Surgery Events of Surgical Site Infection","has_exemption":false,"start_date":"2023-01-17","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05357612","publication_url":"https://clinicaltrials.gov/study/NCT05357612","title":"Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases","has_exemption":false,"start_date":"2023-01-23","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05173324","publication_url":"https://clinicaltrials.gov/study/NCT05173324","title":"Integration of HPV Vaccination and HPV-based Cervical Screening in Young Adult WLWH Into ARV Clinics to Speed the Pathway Towards Cervical Cancer Elimination: the H2VICTORY Trial","has_exemption":false,"start_date":"2023-02-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"International Agency for Research on Cancer","sponsor_slug":"international-agency-for-research-on-cancer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05578976","publication_url":"https://clinicaltrials.gov/study/NCT05578976","title":"A Phase 3, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With R-CHOP Compared to R-CHOP in Subjects With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2023-02-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05739981","publication_url":"https://clinicaltrials.gov/study/NCT05739981","title":"Phase II Study Evaluating the Effect of IMNN-001 on Second Look Laparoscopy (SLL) in Combination With Bevacizumab (BEV) and Neoadjuvant Chemotherapy (NACT) in Newly Diagnosed With Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer","has_exemption":false,"start_date":"2023-02-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Imunon","sponsor_slug":"imunon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05566795","publication_url":"https://clinicaltrials.gov/study/NCT05566795","title":"LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients With Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy","has_exemption":false,"start_date":"2023-02-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Day One Biopharmaceuticals, Inc.","sponsor_slug":"day-one-biopharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05651022","publication_url":"https://clinicaltrials.gov/study/NCT05651022","title":"A Phase 1/2, Open-Label, Multi-Center, Dose Escalation and Expansion Study Evaluating the Safety, Tolerability and Clinical Activity of DECOY20 as Monotherapy and in Combination With Tislelizumab in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-02-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Indaptus Therapeutics, Inc","sponsor_slug":"indaptus-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04556890","publication_url":"https://clinicaltrials.gov/study/NCT04556890","title":"Multi-target Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Major Depressive Disorder (MDD) and Comorbid Pain","has_exemption":false,"start_date":"2023-03-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05570812","publication_url":"https://clinicaltrials.gov/study/NCT05570812","title":"In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living With HIV","has_exemption":false,"start_date":"2023-03-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04685317","publication_url":"https://clinicaltrials.gov/study/NCT04685317","title":"A Pilot Randomized Study of the Use of The Sentinel Device for Cerebral Protection During Atrial Fibrillation Ablation","has_exemption":false,"start_date":"2023-03-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Malini Madhavan","sponsor_slug":"malini-madhavan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05706129","publication_url":"https://clinicaltrials.gov/study/NCT05706129","title":"A Multicenter, Open-Label, Non-Randomized Phase 1/2 Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Patients With Unresectable Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-03-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"ITM Oncologics GmbH","sponsor_slug":"itm-oncologics-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05432804","publication_url":"https://clinicaltrials.gov/study/NCT05432804","title":"A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma","has_exemption":false,"start_date":"2023-03-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05752071","publication_url":"https://clinicaltrials.gov/study/NCT05752071","title":"GaStrointestinal STIMULation As a Treatment of Postoperative IlEus Following Extensive Surgery (STIMULATE). -A Prospective Double-blinded Randomized Controlled Trial","has_exemption":false,"start_date":"2023-04-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Aarhus","sponsor_slug":"university-of-aarhus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05759988","publication_url":"https://clinicaltrials.gov/study/NCT05759988","title":"Cervical Ripening as an Outpatient Method Using the Foley: a Randomized Trial","has_exemption":false,"start_date":"2023-04-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05918835","publication_url":"https://clinicaltrials.gov/study/NCT05918835","title":"Deciphering the Neural Mechanisms of Restrictive Eating in Anorexia Nervosa Using Repetitive Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2023-04-24","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05537935","publication_url":"https://clinicaltrials.gov/study/NCT05537935","title":"Low Dose Naltrexone (LDN) for the Treatment of Chronic Neuropathic Pain in Patients With Human Immunodeficiency Virus (HIV), a Prospective, Pragmatic, Open Label Clinical Trial","has_exemption":false,"start_date":"2023-04-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05483465","publication_url":"https://clinicaltrials.gov/study/NCT05483465","title":"Effects of NAD Restoration on Neurovascular Coupling in Community Dwelling Older Adults","has_exemption":false,"start_date":"2023-05-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05642572","publication_url":"https://clinicaltrials.gov/study/NCT05642572","title":"A Randomized Phase II Study of INC280 (Capmatinib) Plus Osimertinib With or Without Ramucirumab in Participants With EGFR-Mutant, MET-Amplified Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)","has_exemption":false,"start_date":"2023-05-05","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05362032","publication_url":"https://clinicaltrials.gov/study/NCT05362032","title":"Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate","has_exemption":false,"start_date":"2023-05-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05289687","publication_url":"https://clinicaltrials.gov/study/NCT05289687","title":"A Phase II Study of Daratumumab-Hyaluronidase for Chemotherapy-Relapsed/Refractory Minimal Residual Disease (MRD) in T Cell Acute Lymphoblastic Leukemia (T-ALL","has_exemption":false,"start_date":"2023-05-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eastern Cooperative Oncology Group","sponsor_slug":"eastern-cooperative-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05864144","publication_url":"https://clinicaltrials.gov/study/NCT05864144","title":"A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SNS-101 (Anti VISTA) as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Sensei Biotherapeutics, Inc.","sponsor_slug":"sensei-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05919797","publication_url":"https://clinicaltrials.gov/study/NCT05919797","title":"Association of Genetic Variations and Weight Loss Response to Naltrexone/Bupropion","has_exemption":false,"start_date":"2023-06-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05884125","publication_url":"https://clinicaltrials.gov/study/NCT05884125","title":"Promoting Healing of Injured Nerves With Electrical Stimulation Therapy","has_exemption":false,"start_date":"2023-06-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Checkpoint Surgical Inc.","sponsor_slug":"checkpoint-surgical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05926765","publication_url":"https://clinicaltrials.gov/study/NCT05926765","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia","has_exemption":false,"start_date":"2023-06-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"MeiraGTx, LLC","sponsor_slug":"meiragtx-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06087458","publication_url":"https://clinicaltrials.gov/study/NCT06087458","title":"Phase 1/2a Dose Escalation Study of VOY-101 in Patients With Advanced Non- Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2023-06-21","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Perceive Biotherapeutics, Inc.","sponsor_slug":"perceive-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05742607","publication_url":"https://clinicaltrials.gov/study/NCT05742607","title":"Official Title: A Phase II Multicenter, Open Label, Non-randomized Study of Neoadjuvant and Adjuvant Treatment With IPH5201 and Durvalumab in Patients With Resectable, Early-Stage (II to III) Non-Small Cell Lung CancEr (MATISSE)","has_exemption":false,"start_date":"2023-06-23","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Innate Pharma","sponsor_slug":"innate-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05994014","publication_url":"https://clinicaltrials.gov/study/NCT05994014","title":"PET/CT vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease","has_exemption":false,"start_date":"2023-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05552755","publication_url":"https://clinicaltrials.gov/study/NCT05552755","title":"A Phase 1b-2, Multicenter, Trial to Evaluate the Efficacy, Safety, Pharmacokintetics, and Pharmacodynamics of REC-4881 in Patients With Familial Adenomatous Polyposis (FAP)","has_exemption":false,"start_date":"2023-07-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Recursion Pharmaceuticals Inc.","sponsor_slug":"recursion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05929937","publication_url":"https://clinicaltrials.gov/study/NCT05929937","title":"No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair","has_exemption":false,"start_date":"2023-07-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Clayton Petro","sponsor_slug":"clayton-petro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554341","publication_url":"https://clinicaltrials.gov/study/NCT05554341","title":"Nilotinib and Paclitaxel in Patients With Prior Taxane-Treated Solid Tumors: A ComboMATCH Treatment Trial","has_exemption":false,"start_date":"2023-07-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05949593","publication_url":"https://clinicaltrials.gov/study/NCT05949593","title":"PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study)","has_exemption":false,"start_date":"2023-07-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Belite Bio, Inc","sponsor_slug":"belite-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05825066","publication_url":"https://clinicaltrials.gov/study/NCT05825066","title":"Sequential Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2023-08-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05908084","publication_url":"https://clinicaltrials.gov/study/NCT05908084","title":"A Phase 3 Randomized Study to Compare the Efficacy and Safety of the Humacyte Acellular Tissue Engineered Vessel (ATEV) With That of an Autogenous Arteriovenous Fistula (AVF) in Female Patients With End-Stage Renal Disease Requiring Hemodialysis","has_exemption":false,"start_date":"2023-09-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Humacyte, Inc.","sponsor_slug":"humacyte-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05682677","publication_url":"https://clinicaltrials.gov/study/NCT05682677","title":"Combined Neuromodulation and Cognitive Training for Post-mTBI Depression","has_exemption":false,"start_date":"2023-09-19","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06075537","publication_url":"https://clinicaltrials.gov/study/NCT06075537","title":"An Open-Label Extension to Investigate the Long-Term Safety, Tolerability, and Efficacy of DNL310 in Patients With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007","has_exemption":false,"start_date":"2023-09-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Denali Therapeutics Inc.","sponsor_slug":"denali-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05679674","publication_url":"https://clinicaltrials.gov/study/NCT05679674","title":"Phase 2 Trial of Ablative MRI-guided Stereotactic Body Radiation Therapy and Tumor Treating Fields for Locally Advanced Pancreas Cancer","has_exemption":false,"start_date":"2023-09-21","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07103733","publication_url":"https://clinicaltrials.gov/study/NCT07103733","title":"Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY) Ancillary Substudy","has_exemption":false,"start_date":"2023-10-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Annetine Gelijns","sponsor_slug":"annetine-gelijns","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05946629","publication_url":"https://clinicaltrials.gov/study/NCT05946629","title":"A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels","has_exemption":false,"start_date":"2023-10-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"M.A. Med Alliance S.A.","sponsor_slug":"ma-med-alliance-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05980000","publication_url":"https://clinicaltrials.gov/study/NCT05980000","title":"Open-Label, Randomized Phase 2 Trial of Ramucirumab in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-Line Treatment of PD-L1 Positive, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (RM-HNSCC)","has_exemption":false,"start_date":"2023-10-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05063565","publication_url":"https://clinicaltrials.gov/study/NCT05063565","title":"An Open-Label, Prospective, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of TheraSphere™ Followed by Durvalumab (Imfinzi®) With Tremelimumab (Imjudo®) for Hepatocellular Carcinoma (HCC)","has_exemption":false,"start_date":"2023-11-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06029439","publication_url":"https://clinicaltrials.gov/study/NCT06029439","title":"Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants With Major Depressive Disorder","has_exemption":false,"start_date":"2023-11-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Neumora Therapeutics, Inc.","sponsor_slug":"neumora-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05920356","publication_url":"https://clinicaltrials.gov/study/NCT05920356","title":"A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C (CodeBreaK 202)","has_exemption":false,"start_date":"2023-11-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06146842","publication_url":"https://clinicaltrials.gov/study/NCT06146842","title":"A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief With a Lidocaine Test Dose","has_exemption":false,"start_date":"2023-12-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05459636","publication_url":"https://clinicaltrials.gov/study/NCT05459636","title":"Time-Efficient Inspiratory Muscle Strength Training as a New Approach to Lower Blood Pressure, Improve Respiratory Function, and Reduce Exertional Dyspnea in Adults With Obesity","has_exemption":false,"start_date":"2023-12-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05905328","publication_url":"https://clinicaltrials.gov/study/NCT05905328","title":"Phase 1B/2A Study of CTO1681 for the Prevention and Treatment of Cytokine Release Syndrome in Patients With Diffuse Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy","has_exemption":false,"start_date":"2023-12-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"CytoAgents, Inc.","sponsor_slug":"cytoagents-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06001827","publication_url":"https://clinicaltrials.gov/study/NCT06001827","title":"SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study","has_exemption":false,"start_date":"2024-01-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"VenoStent","sponsor_slug":"venostent","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06159335","publication_url":"https://clinicaltrials.gov/study/NCT06159335","title":"Use of 18F-Fluciclovine PET for Discerning Tumor From Treatment Change in Patients With Brain Metastases Undergoing Immunotherapy","has_exemption":false,"start_date":"2024-01-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06162221","publication_url":"https://clinicaltrials.gov/study/NCT06162221","title":"A Platform Study of RAS(ON) Inhibitors in Patients With RAS-Mutated Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2024-01-18","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Revolution Medicines, Inc.","sponsor_slug":"revolution-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06015724","publication_url":"https://clinicaltrials.gov/study/NCT06015724","title":"A Phase 2 Study Evaluating the Efficacy of Anti-CD38 Antibody in Combination With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-01-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06234202","publication_url":"https://clinicaltrials.gov/study/NCT06234202","title":"The Effect of a Bioactive Fabric Sleeve on Recovery in Division I Collegiate Baseball Players","has_exemption":false,"start_date":"2024-02-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06385236","publication_url":"https://clinicaltrials.gov/study/NCT06385236","title":"Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping","has_exemption":false,"start_date":"2024-02-19","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06035120","publication_url":"https://clinicaltrials.gov/study/NCT06035120","title":"An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema: The CONVERT II Trial","has_exemption":false,"start_date":"2024-02-22","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Pulmonx Corporation","sponsor_slug":"pulmonx-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06075745","publication_url":"https://clinicaltrials.gov/study/NCT06075745","title":"Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (CTOT-44)","has_exemption":false,"start_date":"2024-03-05","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06108063","publication_url":"https://clinicaltrials.gov/study/NCT06108063","title":"Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan","has_exemption":false,"start_date":"2024-03-06","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Steadman Philippon Research Institute","sponsor_slug":"steadman-philippon-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06297226","publication_url":"https://clinicaltrials.gov/study/NCT06297226","title":"A Phase 2, Open-Label, Multicenter Study of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)","has_exemption":false,"start_date":"2024-03-21","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","sponsor_slug":"juno-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05460468","publication_url":"https://clinicaltrials.gov/study/NCT05460468","title":"Adaptive Neuromodulation of Working Memory Networks in Aging and Dementia","has_exemption":false,"start_date":"2024-03-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06329401","publication_url":"https://clinicaltrials.gov/study/NCT06329401","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Participants With PPF","has_exemption":false,"start_date":"2024-04-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Avalyn Pharma Inc.","sponsor_slug":"avalyn-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05822609","publication_url":"https://clinicaltrials.gov/study/NCT05822609","title":"Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes","has_exemption":false,"start_date":"2024-04-05","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05980806","publication_url":"https://clinicaltrials.gov/study/NCT05980806","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia","has_exemption":false,"start_date":"2024-04-22","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05988385","publication_url":"https://clinicaltrials.gov/study/NCT05988385","title":"The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults (ESSENTIAL) Study","has_exemption":false,"start_date":"2024-04-22","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"California Pacific Medical Center Research Institute","sponsor_slug":"california-pacific-medical-center-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06110572","publication_url":"https://clinicaltrials.gov/study/NCT06110572","title":"(TESSERACT): Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation (TBI)","has_exemption":false,"start_date":"2024-04-24","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06361498","publication_url":"https://clinicaltrials.gov/study/NCT06361498","title":"Accuracy of Ultrasound for the Evaluation of Percutaneous Gastrostomy Tube Position and Leakage","has_exemption":false,"start_date":"2024-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06087926","publication_url":"https://clinicaltrials.gov/study/NCT06087926","title":"Investigation of Non-invasive Brain Stimulation for the Treatment of Apathy","has_exemption":false,"start_date":"2024-05-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06237452","publication_url":"https://clinicaltrials.gov/study/NCT06237452","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection","has_exemption":false,"start_date":"2024-05-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Vedanta Biosciences, Inc.","sponsor_slug":"vedanta-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06430268","publication_url":"https://clinicaltrials.gov/study/NCT06430268","title":"Efficacy of Non-surgical and Surgical Surface Decontamination Methods on Peri-implantitis-affected Implants: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-05-21","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Andrea Ravida","sponsor_slug":"andrea-ravida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05922761","publication_url":"https://clinicaltrials.gov/study/NCT05922761","title":"An Open-Label, Phase 2 Study to Evaluate the Activity of Belumosudil in Subjects With New Onset and Incipient Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2024-05-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06457919","publication_url":"https://clinicaltrials.gov/study/NCT06457919","title":"A Phase 1b/2 Study Evaluating the Activity of Tinengotinib (TT-00420) in Combination With Androgen Receptor Signaling Inhibitors (ARSIs) in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2024-06-04","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06480240","publication_url":"https://clinicaltrials.gov/study/NCT06480240","title":"A Phase 1/2, Open-Label, Dose-Escalation and Cohort-Expansion Study Evaluating the Safety, Pharmacokinetics, and Therapeutic Activity of OBI-992 in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-06-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"OBI Pharma, Inc","sponsor_slug":"obi-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06353269","publication_url":"https://clinicaltrials.gov/study/NCT06353269","title":"Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections","has_exemption":false,"start_date":"2024-06-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05879835","publication_url":"https://clinicaltrials.gov/study/NCT05879835","title":"Safety and Effectiveness of 4% Tetrasodium Ethylenediaminetetraacetic Acid Catheter Lock Solution in Preventing Central Venous Catheter Occlusions in Children With Intestinal Failure: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-06-21","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"SterileCare Inc.","sponsor_slug":"sterilecare-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06977451","publication_url":"https://clinicaltrials.gov/study/NCT06977451","title":"An Open-Label Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for Amyotrophic Lateral Sclerosis (ALS) Due to an Arg15Leu Pathogenic Variant in CHCHD10","has_exemption":false,"start_date":"2024-06-24","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06424184","publication_url":"https://clinicaltrials.gov/study/NCT06424184","title":"Substance Use Disorder Treatment With Accelerated Repetitive Transcranial Magnetic Stimulation for Depression (START-D)","has_exemption":false,"start_date":"2024-06-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06485778","publication_url":"https://clinicaltrials.gov/study/NCT06485778","title":"Phase 2 Single Arm Trial of Adjuvant Nodal Irradiation Alone in Post Operative Oral Tongue Squamous Cell Carcinoma","has_exemption":false,"start_date":"2024-06-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05705492","publication_url":"https://clinicaltrials.gov/study/NCT05705492","title":"ACTO: A Phase II, Randomized, Placebo-Controlled Study Evaluating Olanzapine in the Management of Cancer Cachexia","has_exemption":false,"start_date":"2024-07-17","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06469801","publication_url":"https://clinicaltrials.gov/study/NCT06469801","title":"Low-Field Bedside MRI for Detection of Acute Brain Injury in Pediatric Extracorporeal Membrane Oxygenation","has_exemption":false,"start_date":"2024-07-23","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Children's Mercy Hospital Kansas City","sponsor_slug":"childrens-mercy-hospital-kansas-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06452589","publication_url":"https://clinicaltrials.gov/study/NCT06452589","title":"A Pre-Market, First-In-Human, Pilot, Interventional, Clinical Investigation to Evaluate Safety and Feasibility of the FieldForce™ Ablation System in Patients With Atrial Fibrillation","has_exemption":false,"start_date":"2024-07-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Field Medical","sponsor_slug":"field-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06226805","publication_url":"https://clinicaltrials.gov/study/NCT06226805","title":"A Multicenter, Double-blinded, Placebo-controlled, Single Ascending Dose, Two-part, Randomized, Phase 2 Clinical Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BB-031 in Acute Ischemic Stroke Patients","has_exemption":false,"start_date":"2024-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Basking Biosciences, Inc.","sponsor_slug":"basking-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06438991","publication_url":"https://clinicaltrials.gov/study/NCT06438991","title":"Epidural Spinal Cord Stimulation for Lower Extremity Motor Function in Spinal Cord Injury","has_exemption":false,"start_date":"2024-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449209","publication_url":"https://clinicaltrials.gov/study/NCT06449209","title":"A Phase II, Multi-site, Open-label, Parallel Group Trial of BNT327 in Combination With Chemotherapy for Participants With Untreated Extensive-stage Small-cell Lung Cancer and Participants With Previously Treated Small-cell Lung Cancer","has_exemption":false,"start_date":"2024-08-05","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06480383","publication_url":"https://clinicaltrials.gov/study/NCT06480383","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Who Have an Inadequate Response to Generalized Anxiety Disorder Treatment","has_exemption":false,"start_date":"2024-08-05","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06332534","publication_url":"https://clinicaltrials.gov/study/NCT06332534","title":"A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib With Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects With Moderately to Severely Active Crohn's Disease and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy","has_exemption":false,"start_date":"2024-08-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05042258","publication_url":"https://clinicaltrials.gov/study/NCT05042258","title":"Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-08-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455293","publication_url":"https://clinicaltrials.gov/study/NCT06455293","title":"The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease","has_exemption":false,"start_date":"2024-08-19","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Joshua Woolley, MD, PhD","sponsor_slug":"joshua-woolley-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06406751","publication_url":"https://clinicaltrials.gov/study/NCT06406751","title":"Microbiome Effects of Extended Use of MI Paste in Elderly Removable Denture Wearers","has_exemption":false,"start_date":"2024-08-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06445959","publication_url":"https://clinicaltrials.gov/study/NCT06445959","title":"Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib","has_exemption":false,"start_date":"2024-08-29","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06150885","publication_url":"https://clinicaltrials.gov/study/NCT06150885","title":"A Single Arm, Open Label, Dose-escalation Phase I and Dose-expansion Phase IIa Clinical Study to Evaluate the Feasibility, Safety, and Efficacy of Allogeneic Chimeric Antigen Receptor (CAR) Gamma-Delta T Cells CAR001 in Subjects with Relapsed/refractory Solid Tumors","has_exemption":false,"start_date":"2024-09-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ever Supreme Bio Technology Co., Ltd.","sponsor_slug":"ever-supreme-bio-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06353997","publication_url":"https://clinicaltrials.gov/study/NCT06353997","title":"A Phase II, Single-arm, Multi-center, Open-label Study of Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as an Induction Immunotherapy for Stage II/III TNBC Patients","has_exemption":false,"start_date":"2024-09-05","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Providence Health & Services","sponsor_slug":"providence-health-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06274047","publication_url":"https://clinicaltrials.gov/study/NCT06274047","title":"PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.","has_exemption":false,"start_date":"2024-09-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06417775","publication_url":"https://clinicaltrials.gov/study/NCT06417775","title":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Ubrogepant for the Preventive Treatment of Menstrual Migraine With an Open-Label Extension","has_exemption":false,"start_date":"2024-09-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655740","publication_url":"https://clinicaltrials.gov/study/NCT06655740","title":"A Pilot Human Study of the Safety, Tolerability and Effectiveness of the Aqua Medical Circumferential RF Vapor (RFV) Ablation System for Duodenal Mucosal Ablation for the Management of Insulin Requiring Type-2 Diabetes Mellitus","has_exemption":false,"start_date":"2024-10-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Aqua Medical, Inc.","sponsor_slug":"aqua-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06541249","publication_url":"https://clinicaltrials.gov/study/NCT06541249","title":"MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial","has_exemption":false,"start_date":"2024-10-02","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625671","publication_url":"https://clinicaltrials.gov/study/NCT06625671","title":"A Randomized, Double-Blind, Phase 1/2a Study to Evaluate the Safety, Tolerability, PK and PD of DB-2304 for Injection in Healthy Adult Participants and Participants With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus","has_exemption":false,"start_date":"2024-10-04","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411990","publication_url":"https://clinicaltrials.gov/study/NCT06411990","title":"Laser In Situ Fenestration for Endovascular Aortic Repair (LIFE) Study","has_exemption":false,"start_date":"2024-10-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Jonathan Bath","sponsor_slug":"jonathan-bath","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06564844","publication_url":"https://clinicaltrials.gov/study/NCT06564844","title":"A Phase III, Randomised, Open-label, Global Study of Adjuvant Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma Non-small Cell Lung Cancer Who Are ctDNA-positive or Have High-risk Pathological Features (TROPION-Lung12)","has_exemption":false,"start_date":"2024-10-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06724822","publication_url":"https://clinicaltrials.gov/study/NCT06724822","title":"A Pilot Human Investigation of the Safety, Tolerability, Effectiveness of the Aqua Medical Circumferential RF Vapor (RFV) Ablation System for Duodenal Mucosal Repeat Ablation Treatment for the Management of Type-2 Diabetes Mellitus (STEAM T-2 DM Retreatment Study) in Patients Who Were Non-Responders to Initial Duodenal Mucosal Ablation Treatment","has_exemption":false,"start_date":"2024-11-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Aqua Medical, Inc.","sponsor_slug":"aqua-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06228053","publication_url":"https://clinicaltrials.gov/study/NCT06228053","title":"A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer, the SYNERGY-201 Trial","has_exemption":false,"start_date":"2024-11-18","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Syntrix Biosystems, Inc.","sponsor_slug":"syntrix-biosystems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06369285","publication_url":"https://clinicaltrials.gov/study/NCT06369285","title":"A Phase 2 Study of Alisertib in Combination With Endocrine Therapy in Patients With HR+, HER2-negative Recurrent or Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-11-19","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Puma Biotechnology, Inc.","sponsor_slug":"puma-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06701903","publication_url":"https://clinicaltrials.gov/study/NCT06701903","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Who Have an Inadequate Response to Generalized Anxiety Disorder Treatment","has_exemption":false,"start_date":"2024-11-21","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06747858","publication_url":"https://clinicaltrials.gov/study/NCT06747858","title":"A Phase 2, Open-label, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Efficacy of ARCT-032 in People With Cystic Fibrosis","has_exemption":false,"start_date":"2024-12-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Arcturus Therapeutics, Inc.","sponsor_slug":"arcturus-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06771323","publication_url":"https://clinicaltrials.gov/study/NCT06771323","title":"Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia","has_exemption":false,"start_date":"2024-12-17","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06395636","publication_url":"https://clinicaltrials.gov/study/NCT06395636","title":"Using the Fitbit for Early Detection of Infection and Reduction of Healthcare Utilization After Discharge in Pediatric Surgical Patients","has_exemption":false,"start_date":"2025-01-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","sponsor_slug":"ann-robert-h-lurie-childrens-hospital-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596291","publication_url":"https://clinicaltrials.gov/study/NCT06596291","title":"First-In-Human Phase 1b/2a Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adult Participants With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization","has_exemption":false,"start_date":"2025-01-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Cyllene Therapeutics","sponsor_slug":"cyllene-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06472453","publication_url":"https://clinicaltrials.gov/study/NCT06472453","title":"Prospective Comparative Evaluation of Alveolar Ridge Preservation: Mixing Allograft With Xenograft VS. Allograft Alone in Atraumatic Extraction Sockets","has_exemption":false,"start_date":"2025-01-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06814522","publication_url":"https://clinicaltrials.gov/study/NCT06814522","title":"Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]","has_exemption":false,"start_date":"2025-01-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06754735","publication_url":"https://clinicaltrials.gov/study/NCT06754735","title":"A Multi-national, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Venous Leg Ulcers","has_exemption":false,"start_date":"2025-01-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"AOTI Ltd.","sponsor_slug":"aoti-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06327945","publication_url":"https://clinicaltrials.gov/study/NCT06327945","title":"Transplanting Lungs From Uncontrolled Donation After Circulatory Death: An Early Phase Clinical Trial","has_exemption":false,"start_date":"2025-01-24","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06780202","publication_url":"https://clinicaltrials.gov/study/NCT06780202","title":"Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients","has_exemption":false,"start_date":"2025-01-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05904132","publication_url":"https://clinicaltrials.gov/study/NCT05904132","title":"Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease","has_exemption":false,"start_date":"2025-01-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06741527","publication_url":"https://clinicaltrials.gov/study/NCT06741527","title":"Post Market Confirmatory Interventional Clinical Study of the Integrity Implant System Used for Rotator Cuff Tear Augmentation","has_exemption":false,"start_date":"2025-02-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Anika Therapeutics, Inc.","sponsor_slug":"anika-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05820893","publication_url":"https://clinicaltrials.gov/study/NCT05820893","title":"BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases; CMA5- Functional Metagenomics in GWI-related Gut Dysfunction","has_exemption":false,"start_date":"2025-02-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06495593","publication_url":"https://clinicaltrials.gov/study/NCT06495593","title":"Identifying Ocrelizumab-resistant Lymphocytes in Lymphoid Tissue in Multiple Sclerosis","has_exemption":false,"start_date":"2025-02-04","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06541847","publication_url":"https://clinicaltrials.gov/study/NCT06541847","title":"A Phase 2, Open-Label, Single Arm, Non-Controlled, Single-Stage Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Plexiform Neurofibroma and Neurofibromatosis Type 1","has_exemption":false,"start_date":"2025-02-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Healx Limited","sponsor_slug":"healx-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06275282","publication_url":"https://clinicaltrials.gov/study/NCT06275282","title":"Regenerative Peripheral Nerve Interfaces to Enhance Function and Sensation in People With Transfemoral Amputation","has_exemption":false,"start_date":"2025-02-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06929923","publication_url":"https://clinicaltrials.gov/study/NCT06929923","title":"A Double-Blind, Randomized Study of Clinical Efficacy of Hypothermic Therapy Following Concussion in Adolescent Athletes as Compared to a Sham-Controlled Population","has_exemption":false,"start_date":"2025-02-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"TecTraum Inc.","sponsor_slug":"tectraum-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827977","publication_url":"https://clinicaltrials.gov/study/NCT06827977","title":"A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864988","publication_url":"https://clinicaltrials.gov/study/NCT06864988","title":"A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"4D Molecular Therapeutics","sponsor_slug":"4d-molecular-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792695","publication_url":"https://clinicaltrials.gov/study/NCT06792695","title":"A Phase II, Open-label, Multicenter, Master Protocol to Evaluate the Safety and Efficacy of Novel Study Interventions and Combinations in Participants With Colorectal Cancer (CANTOR)","has_exemption":false,"start_date":"2025-03-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06726265","publication_url":"https://clinicaltrials.gov/study/NCT06726265","title":"TACTI-004, a Double-Blinded, Randomized Phase 3 Trial in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Receiving Eftilagimod Alfa (MHC Class II Agonist) in Combination With Pembrolizumab (PD-1 Antagonist) and Chemotherapy.","has_exemption":false,"start_date":"2025-03-21","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Immutep S.A.S.","sponsor_slug":"immutep-sas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06635785","publication_url":"https://clinicaltrials.gov/study/NCT06635785","title":"Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors","has_exemption":false,"start_date":"2025-03-26","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"OncoC4, Inc.","sponsor_slug":"oncoc4-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06413368","publication_url":"https://clinicaltrials.gov/study/NCT06413368","title":"Maralixibat in Patients With Cystic Fibrosis and Constipation, A Within-Subjects Pilot Study","has_exemption":false,"start_date":"2025-04-09","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Los Angeles","sponsor_slug":"childrens-hospital-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06212336","publication_url":"https://clinicaltrials.gov/study/NCT06212336","title":"Efficacy, Tolerability and Safety of New or Repurposed Drugs Against Lassa Fever in West African Countries","has_exemption":false,"start_date":"2025-05-02","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Irrua Specialist Teaching Hospital","sponsor_slug":"irrua-specialist-teaching-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06770998","publication_url":"https://clinicaltrials.gov/study/NCT06770998","title":"A Prospective Randomized Study of a Novel EEG Neurofeedback System for the Treatment of PTSD Using Machine Learning-Based Amygdala Biomarkers","has_exemption":false,"start_date":"2025-05-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Foundation for Atlanta Veterans Education and Research, Inc.","sponsor_slug":"foundation-for-atlanta-veterans-education-and-research-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06982105","publication_url":"https://clinicaltrials.gov/study/NCT06982105","title":"Comparing Optimal Step-down Therapy for Children With Invasive MRSA Trimethoprim-Sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections","has_exemption":false,"start_date":"2025-05-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06854393","publication_url":"https://clinicaltrials.gov/study/NCT06854393","title":"Lacripep, a Novel Investigational Agent, for Corneal Wound Healing and Ocular Surface Homeostasis","has_exemption":false,"start_date":"2025-05-23","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","sponsor_slug":"henry-m-jackson-foundation-for-the-advancement-of-military-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07012395","publication_url":"https://clinicaltrials.gov/study/NCT07012395","title":"Phase 2 Platform Trial to Assess the Efficacy and Safety of Long-acting Antibodies as Single Agents and in Combinations for Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2025-05-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Spyre Therapeutics, Inc.","sponsor_slug":"spyre-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533579","publication_url":"https://clinicaltrials.gov/study/NCT06533579","title":"A Phase 1/2 Safety, Dose-finding, and Pharmacokinetics Study of VNX-101 Gene Therapy in Patients With Relapsed or Refractory CD19-Positive Hematologic Malignancies (SENTRY-CD19)","has_exemption":false,"start_date":"2025-05-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Vironexis Biotherapeutics Inc.","sponsor_slug":"vironexis-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06922591","publication_url":"https://clinicaltrials.gov/study/NCT06922591","title":"A Phase 1/2, Multicenter, Open-Label Study to Evaluate Safety, Tolerability & Antitumor Activity of TNG462 in Combination With Other Agents in Patients With Pancreatic Cancer With MTAP Loss and Pancreatic or Non-Small Cell Lung Cancer With MTAP Loss & RAS Mutation","has_exemption":false,"start_date":"2025-05-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Tango Therapeutics, Inc.","sponsor_slug":"tango-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736769","publication_url":"https://clinicaltrials.gov/study/NCT06736769","title":"\"KETTLE\" Trial: Ketamine Effects on Learning In Eating Disorders","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Amanda Downey, MD","sponsor_slug":"amanda-downey-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06575426","publication_url":"https://clinicaltrials.gov/study/NCT06575426","title":"A Phase I/IIa, Single Site, Open-Label, Ascending Dose Study to Evaluate the Safety and Efficacy of OPF-310 [Encapsulated Porcine Islet Cells for Xenotransplantation] in Subjects With Type 1 Diabetes Mellitus","has_exemption":false,"start_date":"2025-06-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Factory, Inc.","sponsor_slug":"otsuka-pharmaceutical-factory-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06993844","publication_url":"https://clinicaltrials.gov/study/NCT06993844","title":"A Phase 1/2, Open-label, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ETX-636, a Pan-mutant-selective PI3Kα Inhibitor, as Monotherapy and in Combination With Other Anticancer Therapies in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-06-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ensem Therapeutics","sponsor_slug":"ensem-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06679855","publication_url":"https://clinicaltrials.gov/study/NCT06679855","title":"Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial","has_exemption":false,"start_date":"2025-06-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"NICHD Neonatal Research Network","sponsor_slug":"nichd-neonatal-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06871774","publication_url":"https://clinicaltrials.gov/study/NCT06871774","title":"Comparative Efficacy of Single vs. Dual Perclose Devices for Large-Bore Access Closure in Transcatheter Aortic Valve Replacement: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-06-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959277","publication_url":"https://clinicaltrials.gov/study/NCT06959277","title":"Balance4Mobility: Effects of Walkasins Use on Clinical Outcomes of Gait and Balance Function in Individuals With Peripheral Neuropathy and Balance Problems - A Randomized Control Trial","has_exemption":false,"start_date":"2025-06-17","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"RxFunction Inc.","sponsor_slug":"rxfunction-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06608823","publication_url":"https://clinicaltrials.gov/study/NCT06608823","title":"A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Transcatheter Heart Valve System Versus Surgical Valve Replacement in Patients With Aortic Regurgitation","has_exemption":false,"start_date":"2025-06-18","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"JenaValve Technology, Inc.","sponsor_slug":"jenavalve-technology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07021313","publication_url":"https://clinicaltrials.gov/study/NCT07021313","title":"Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation","has_exemption":false,"start_date":"2025-06-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"R&D Cardiologie","sponsor_slug":"rd-cardiologie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07046832","publication_url":"https://clinicaltrials.gov/study/NCT07046832","title":"Clinical Evaluation of an Intra-procedural 3D Needle Guidance Platform for Soft Tissue Tumors or Organs Requiring Percutaneous Biopsy as an Adjunct to Standard Image Guidance","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"MediView XR, Inc.","sponsor_slug":"mediview-xr-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06963684","publication_url":"https://clinicaltrials.gov/study/NCT06963684","title":"Glaucoma Laser Assessment of Stability and Sustainability: Evaluating Long-Term Stability and Retreatment Efficacy of DSLT in Patients With Ocular Hypertension, Glaucoma Suspects, and Mild/Moderate POAG.","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Twin Cities Eye Consultants","sponsor_slug":"twin-cities-eye-consultants","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990217","publication_url":"https://clinicaltrials.gov/study/NCT06990217","title":"Comparison of Oxytocin Dosing Regimen' Low Versus High, in Gravida Women With BMI 30 and Above Undergoing Induction of Labor","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"HaEmek Medical Center, Israel","sponsor_slug":"haemek-medical-center-israel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05574465","publication_url":"https://clinicaltrials.gov/study/NCT05574465","title":"Esophageal Manometry During Recovery From Endotracheal Intubation","has_exemption":false,"start_date":"2025-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06549348","publication_url":"https://clinicaltrials.gov/study/NCT06549348","title":"Radiation Free Study","has_exemption":false,"start_date":"2025-07-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Philips Clinical & Medical Affairs Global","sponsor_slug":"philips-clinical-medical-affairs-global","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06828796","publication_url":"https://clinicaltrials.gov/study/NCT06828796","title":"Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide","has_exemption":false,"start_date":"2025-07-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Northside Hospital, Inc.","sponsor_slug":"northside-hospital-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06970665","publication_url":"https://clinicaltrials.gov/study/NCT06970665","title":"A Phase 3/4, Multicenter, Single-arm Clinical Study to Assess the Safety of Intravitreal Administration of ASP3021 in Participants in Japan With Geographic Atrophy Secondary to Age-related Macular Degeneration","has_exemption":false,"start_date":"2025-07-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Inc","sponsor_slug":"astellas-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06927999","publication_url":"https://clinicaltrials.gov/study/NCT06927999","title":"An Outpatient, Randomized, Double-Blinded, Placebo-Controlled, Cross-Over Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria","has_exemption":false,"start_date":"2025-07-09","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"ARS Pharmaceuticals, Inc.","sponsor_slug":"ars-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915324","publication_url":"https://clinicaltrials.gov/study/NCT06915324","title":"Transcranial Direct Current Stimulation (tDCS) of Brain Fog in Patients With Post Treatment Lyme Disease","has_exemption":false,"start_date":"2025-07-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07017998","publication_url":"https://clinicaltrials.gov/study/NCT07017998","title":"Mild Therapeutic Hypothermia for Tinnitus Management","has_exemption":false,"start_date":"2025-07-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Restorear Devices LLC","sponsor_slug":"restorear-devices-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06989567","publication_url":"https://clinicaltrials.gov/study/NCT06989567","title":"A Phase III, Multi-Center, Double-Blind, Placebo-Controlled, Randomized Study of Intravenous L-Citrulline in Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis in Children, Adolescents and Young Adults (6 to 21 Years)","has_exemption":false,"start_date":"2025-07-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Asklepion Pharmaceuticals, LLC","sponsor_slug":"asklepion-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07146022","publication_url":"https://clinicaltrials.gov/study/NCT07146022","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Dose Study to Evaluate the Efficacy and Safety of VDPHL01 in Female Subjects With Androgenetic Alopecia","has_exemption":false,"start_date":"2025-07-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Veradermics, Inc.","sponsor_slug":"veradermics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06937320","publication_url":"https://clinicaltrials.gov/study/NCT06937320","title":"Chronic Effects of Exogenous Ketone Administration in Heart Failure With Preserved Ejection Fraction","has_exemption":false,"start_date":"2025-07-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07064668","publication_url":"https://clinicaltrials.gov/study/NCT07064668","title":"Prospective Study on the Synergistic Effect of Tauroursodeoxycholic Acid Combined With Immunotherapy in Hepatocellular Carcinoma","has_exemption":false,"start_date":"2025-07-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Tongji Hospital","sponsor_slug":"tongji-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07058662","publication_url":"https://clinicaltrials.gov/study/NCT07058662","title":"A Phase 1/2, Open-label Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.","has_exemption":false,"start_date":"2025-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Belief BioMed (Beijing) Co., Ltd","sponsor_slug":"belief-biomed-beijing-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06168058","publication_url":"https://clinicaltrials.gov/study/NCT06168058","title":"Randomized Controlled, Single-Blinded, Parallel-Group Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices (EMBOLIZE) Trial","has_exemption":false,"start_date":"2025-08-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07113067","publication_url":"https://clinicaltrials.gov/study/NCT07113067","title":"Accelerated rTMS for Post-stroke Apathy: A Double-blind Randomized Controlled Trial","has_exemption":false,"start_date":"2025-08-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05337241","publication_url":"https://clinicaltrials.gov/study/NCT05337241","title":"Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT","has_exemption":false,"start_date":"2025-08-09","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Thermedical, Inc.","sponsor_slug":"thermedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06636669","publication_url":"https://clinicaltrials.gov/study/NCT06636669","title":"The Role of Peri-operative Adjunctive Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and Knee","has_exemption":false,"start_date":"2025-08-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06543277","publication_url":"https://clinicaltrials.gov/study/NCT06543277","title":"Safety and Feasibility of Paired taVNS With Upper Limb Rehabilitation in Incomplete Spinal Cord Injury","has_exemption":false,"start_date":"2025-08-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07088055","publication_url":"https://clinicaltrials.gov/study/NCT07088055","title":"Multi-center, 6-month, Randomized, and Controlled Trial to Compare the Effects of Myo Munchee Therapy and Oral Motor Therapy (OMT) in Pediatric Patients (Aged 3-5 Years) to Treat Maxillary Deficiency and Orofacial Myofunctional Dysfunction (OMD).","has_exemption":false,"start_date":"2025-08-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Myo Munchee (Operations) Pty Ltd","sponsor_slug":"myo-munchee-operations-pty-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07200908","publication_url":"https://clinicaltrials.gov/study/NCT07200908","title":"A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)","has_exemption":false,"start_date":"2025-08-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Mirum Pharmaceuticals, Inc.","sponsor_slug":"mirum-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06960213","publication_url":"https://clinicaltrials.gov/study/NCT06960213","title":"STOP-HAE: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema","has_exemption":false,"start_date":"2025-08-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"ADARx Pharmaceuticals, Inc.","sponsor_slug":"adarx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07083765","publication_url":"https://clinicaltrials.gov/study/NCT07083765","title":"A Prospective Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation Using the Dehydrated Alcohol Injection, USP Administered With the Peregrine System™ Infusion Catheter in Subjects With Hypertension, in the Absence of Antihypertensive Medications","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ablative Solutions, Inc.","sponsor_slug":"ablative-solutions-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06910241","publication_url":"https://clinicaltrials.gov/study/NCT06910241","title":"Lidocaine Versus Diphenhydramine to Achieve Local Anesthesia for Laceration Repairs","has_exemption":false,"start_date":"2025-09-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Florida Atlantic University","sponsor_slug":"florida-atlantic-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06784466","publication_url":"https://clinicaltrials.gov/study/NCT06784466","title":"Coherent Sine Burst Electroporation (CSE) Ablation System US Investigational Device Exemption (IDE) Study for Patients With Atrial Fibrillation","has_exemption":false,"start_date":"2025-09-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Arga Medtech SA","sponsor_slug":"arga-medtech-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07145801","publication_url":"https://clinicaltrials.gov/study/NCT07145801","title":"Contrast-Enhanced Ultrasound Evaluation of Radioembolization Treatment Response","has_exemption":false,"start_date":"2025-09-11","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07159763","publication_url":"https://clinicaltrials.gov/study/NCT07159763","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CD388, a Novel Long-Acting Antiviral Conjugate, for the Prevention of Influenza in Adults and Adolescents at Higher Risk of Developing Influenza Complications","has_exemption":false,"start_date":"2025-09-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","sponsor_slug":"cidara-therapeutics-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07046078","publication_url":"https://clinicaltrials.gov/study/NCT07046078","title":"Pilot Study of FLAG-Ida Followed Immediately by Reduced-Intensity Allogeneic HCT for Adults Age 60 and Older With Newly Diagnosed Adverse-Risk AML or Other High-Grade Myeloid Neoplasm","has_exemption":false,"start_date":"2025-09-26","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05067257","publication_url":"https://clinicaltrials.gov/study/NCT05067257","title":"A Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer","has_exemption":false,"start_date":"2025-09-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Sorrento Therapeutics, Inc.","sponsor_slug":"sorrento-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095127","publication_url":"https://clinicaltrials.gov/study/NCT07095127","title":"An Open-Label, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants With Immune Thrombocytopenia","has_exemption":false,"start_date":"2025-09-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Nuvig Therapeutics, Inc.","sponsor_slug":"nuvig-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07155265","publication_url":"https://clinicaltrials.gov/study/NCT07155265","title":"ClinicalTrials.Gov PRS Field-by-Field Checklist & Results Module Templates - REMIMID-ICU","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Yancheng First People's Hospital","sponsor_slug":"yancheng-first-peoples-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07608614","publication_url":"https://clinicaltrials.gov/study/NCT07608614","title":"Augmented Neurophysiology of Sleep and Performance Readiness","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06786325","publication_url":"https://clinicaltrials.gov/study/NCT06786325","title":"A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?","has_exemption":false,"start_date":"2025-10-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Anna Rose Childress, Ph.D.","sponsor_slug":"anna-rose-childress-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07211373","publication_url":"https://clinicaltrials.gov/study/NCT07211373","title":"Advancing Student Suicide Interventions With Scalable Technologies (ASSIST)","has_exemption":false,"start_date":"2025-10-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Massachusetts, Amherst","sponsor_slug":"university-of-massachusetts-amherst","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07266805","publication_url":"https://clinicaltrials.gov/study/NCT07266805","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, 3-Part Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant Extended-release (XR) Tablet for Prophylaxis and Deucrictibant Immediate-release (IR) Capsule for On-demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency","has_exemption":false,"start_date":"2025-10-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Pharvaris Netherlands B.V.","sponsor_slug":"pharvaris-netherlands-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06431776","publication_url":"https://clinicaltrials.gov/study/NCT06431776","title":"An Open-label, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).","has_exemption":false,"start_date":"2025-10-22","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Savara Inc.","sponsor_slug":"savara-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06809803","publication_url":"https://clinicaltrials.gov/study/NCT06809803","title":"Safety, Convenience, and Tolerability of a Nightly Single Oral Dose of Extended-release Sodium Oxybate in Children","has_exemption":false,"start_date":"2025-10-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05904626","publication_url":"https://clinicaltrials.gov/study/NCT05904626","title":"A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Basket Study to Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA","has_exemption":false,"start_date":"2025-10-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Elgan Pharma Ltd.","sponsor_slug":"elgan-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07640503","publication_url":"https://clinicaltrials.gov/study/NCT07640503","title":"Lamivudine in Individuals With Rett Syndrome: Clinical, Biochemical, and Cellular Evaluation","has_exemption":false,"start_date":"2025-11-05","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Maria Denise Fernandes Carvalho de Andrade","sponsor_slug":"maria-denise-fernandes-carvalho-de-andrade","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07166939","publication_url":"https://clinicaltrials.gov/study/NCT07166939","title":"A Phase 4, Multicenter, Cluster Randomized, Open-label, Intervention Versus Usual Care, Controlled Study on the Effect of Emergency Department Initiation of Airsupra on Asthma Outcomes","has_exemption":false,"start_date":"2025-11-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07148232","publication_url":"https://clinicaltrials.gov/study/NCT07148232","title":"Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness","has_exemption":false,"start_date":"2025-11-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221344","publication_url":"https://clinicaltrials.gov/study/NCT07221344","title":"A Phase 1/2a Placebo-Controlled Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease","has_exemption":false,"start_date":"2025-11-18","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Arrowhead Pharmaceuticals","sponsor_slug":"arrowhead-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217015","publication_url":"https://clinicaltrials.gov/study/NCT07217015","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study With an Open-label Period Investigating the Efficacy and Safety Profile of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-11-24","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Kymera Therapeutics, Inc.","sponsor_slug":"kymera-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209397","publication_url":"https://clinicaltrials.gov/study/NCT07209397","title":"A Randomized, Prospective, Multicenter, Double-Blind, Sham-Controlled Study to Assess the MORPHEUSV Radiofrequency (RF) Device in the Treatment of Female Patients With Idiopathic Overactive Bladder (OAB) With Urge Incontinence and/or Urge-Predominant Mixed Incontinence","has_exemption":false,"start_date":"2025-11-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"InMode MD Ltd.","sponsor_slug":"inmode-md-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217925","publication_url":"https://clinicaltrials.gov/study/NCT07217925","title":"Exploring the Influence of Neurofeedback on the Well-Being of People With Symptoms of Obsessive Compulsive Disorder and Post-traumatic Stress Symptoms","has_exemption":false,"start_date":"2025-11-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Wayne State University","sponsor_slug":"wayne-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07268638","publication_url":"https://clinicaltrials.gov/study/NCT07268638","title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Praliciguat in Patients With Biopsy-Confirmed Focal Segmental Glomerulosclerosis","has_exemption":false,"start_date":"2025-12-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Akebia Therapeutics","sponsor_slug":"akebia-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290569","publication_url":"https://clinicaltrials.gov/study/NCT07290569","title":"A Multicenter, Randomized, Double-blinded, Placebo-controlled, Dose-range Finding Study of ORKA-001 in Participants With Moderate-to-Severe Plaque Psoriasis","has_exemption":false,"start_date":"2025-12-03","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Oruka Therapeutics, Inc.","sponsor_slug":"oruka-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06910943","publication_url":"https://clinicaltrials.gov/study/NCT06910943","title":"A Phase 2b/3 Randomized Open-Label Dose-Selection Study With Open-Label Extension and Randomized Double-Blind, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of Choline Chloride for Injection (Low Dose and High Dose) Versus Placebo in Adolescents and Adults With Intestinal Failure Receiving Long-Term Parenteral Support","has_exemption":false,"start_date":"2025-12-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Protara Therapeutics","sponsor_slug":"protara-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07072468","publication_url":"https://clinicaltrials.gov/study/NCT07072468","title":"A Randomized, Double-blind, Placebo-controlled Crossover Study to Evaluate Analgesic Efficacy, Safety and Tolerability of Repeated Doses of Topical VMD-3866 in Patients With Chemotherapy-induced Peripheral Neuropathy (CIPN)","has_exemption":false,"start_date":"2025-12-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"VM Therapeutics LLC","sponsor_slug":"vm-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07023185","publication_url":"https://clinicaltrials.gov/study/NCT07023185","title":"Cold and Compression After Total Knee Arthroplasty for Pain Attenuation: A Randomized, Controlled Trial","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ochsner Health System","sponsor_slug":"ochsner-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07368933","publication_url":"https://clinicaltrials.gov/study/NCT07368933","title":"ADVANCEd NanoTherapies SirPlux Duo™ Dual API-Coated PTCA Balloon Catheter to Treat Coronary In-stent Restenosis (ISR) and de Novo Lesions","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Advanced NanoTherapies","sponsor_slug":"advanced-nanotherapies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06904287","publication_url":"https://clinicaltrials.gov/study/NCT06904287","title":"Evaluating the Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines in the Emergency Department","has_exemption":false,"start_date":"2025-12-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07246590","publication_url":"https://clinicaltrials.gov/study/NCT07246590","title":"COVE-2: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and Safety of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris)","has_exemption":false,"start_date":"2025-12-17","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Verrica Pharmaceuticals Inc.","sponsor_slug":"verrica-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07110337","publication_url":"https://clinicaltrials.gov/study/NCT07110337","title":"A Prospective Study to Evaluate the Use of the Minder Device to Aid in Developing a Treatment Plan After Inconclusive Prolonged EEG in Patients With Epilepsy","has_exemption":false,"start_date":"2025-12-23","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Epiminder America, Inc.","sponsor_slug":"epiminder-america-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07239986","publication_url":"https://clinicaltrials.gov/study/NCT07239986","title":"An Open-label, Multicenter Phase 2 Clinical Study on the Efficacy and Safety of BB102 in Patients With Advanced or Unresectable FGF19-overexpressing Hepatocellular Carcinoma","has_exemption":false,"start_date":"2025-12-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Broadenbio Ltd., Co.","sponsor_slug":"broadenbio-ltd-co","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06700239","publication_url":"https://clinicaltrials.gov/study/NCT06700239","title":"The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US","has_exemption":false,"start_date":"2025-12-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Micro Interventional Devices","sponsor_slug":"micro-interventional-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287371","publication_url":"https://clinicaltrials.gov/study/NCT07287371","title":"Randomized Trial of Sucrosomial Iron Vs Intravenous Iron for Preoperative Anemia (RSIVI)","has_exemption":false,"start_date":"2025-12-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07294118","publication_url":"https://clinicaltrials.gov/study/NCT07294118","title":"Endovascular Infusion of Lidocaine and Steroids in the Middle Meningeal Artery for Pain Management in Spontaneous Subarachnoid Hemorrhage Patients","has_exemption":false,"start_date":"2026-01-02","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298967","publication_url":"https://clinicaltrials.gov/study/NCT07298967","title":"ORegon CHild Absenteeism Due to Respiratory Disease Study - Air Surveillance","has_exemption":false,"start_date":"2026-01-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07492108","publication_url":"https://clinicaltrials.gov/study/NCT07492108","title":"Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With Gastroparesis Like Symptoms: A Randomized, Double-Blind, Sham-Controlled Pilot Study","has_exemption":false,"start_date":"2026-01-08","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07355062","publication_url":"https://clinicaltrials.gov/study/NCT07355062","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Veverimer in Adults With CKD and Metabolic Acidosis","has_exemption":false,"start_date":"2026-01-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Renibus Therapeutics, Inc.","sponsor_slug":"renibus-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07040592","publication_url":"https://clinicaltrials.gov/study/NCT07040592","title":"Feasibility, Acceptability, and Preliminary Efficacy of Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: An Open-Label Pilot Study","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011147","publication_url":"https://clinicaltrials.gov/study/NCT07011147","title":"Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery","has_exemption":false,"start_date":"2026-01-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07316166","publication_url":"https://clinicaltrials.gov/study/NCT07316166","title":"Comparison of Suprainguinal Fascia Iliac Block With and Without Dexmedetomidine as an Adjunct to Ropivacaine for Postoperative Analgesia Following Hip Surgery: a Randomized, Double-blinded Study.","has_exemption":false,"start_date":"2026-01-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07354880","publication_url":"https://clinicaltrials.gov/study/NCT07354880","title":"Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease","has_exemption":false,"start_date":"2026-01-20","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University Medical Centre Ljubljana","sponsor_slug":"university-medical-centre-ljubljana","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07274917","publication_url":"https://clinicaltrials.gov/study/NCT07274917","title":"The Efficacy and Safety of Stereotactic Radiotherapy for Treatment-Resistant Depression: An Open-Label Exploratory Study","has_exemption":false,"start_date":"2026-01-26","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Capital Medical University","sponsor_slug":"capital-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07484009","publication_url":"https://clinicaltrials.gov/study/NCT07484009","title":"ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure: the ReDS-SAFE HF II Trial","has_exemption":false,"start_date":"2026-01-29","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","sponsor_slug":"fundacion-para-la-investigacion-biomedica-del-hospital-universitario-ramon-y-cajal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05052541","publication_url":"https://clinicaltrials.gov/study/NCT05052541","title":"Safety and Efficacy of Oral Cannabis in Chronic Spine Pain","has_exemption":false,"start_date":"2026-01-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06513208","publication_url":"https://clinicaltrials.gov/study/NCT06513208","title":"Ketorolac Effects on Post-operative Pain and Lumbar Fusion: a Double Blind Randomized Controlled Trial","has_exemption":false,"start_date":"2026-01-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland St. Joseph Medical Center","sponsor_slug":"university-of-maryland-st-joseph-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07296445","publication_url":"https://clinicaltrials.gov/study/NCT07296445","title":"LATITUDE - A Phase 3, Randomized, Open-Label, 3-Cohort, 2-Period, 2-Sequence, Crossover Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of Oral Arsenic Trioxide Versus Intravenous Arsenic Trioxide for Consolidation Therapy in Participants With Newly Diagnosed, Non-High-Risk, Acute Promyelocytic Leukemia","has_exemption":false,"start_date":"2026-01-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"SDK Therapeutics, Inc.","sponsor_slug":"sdk-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224698","publication_url":"https://clinicaltrials.gov/study/NCT07224698","title":"Phase 2 Multicenter Randomized Placebo-controlled, Double-blind, Parallel Study to Assess the Safety and Efficacy of Inhaled Cannabis in Veterans for Treatment of Posttraumatic Stress Disorder (PTSD)","has_exemption":false,"start_date":"2026-02-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Multidisciplinary Association for Psychedelic Studies","sponsor_slug":"multidisciplinary-association-for-psychedelic-studies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07396168","publication_url":"https://clinicaltrials.gov/study/NCT07396168","title":"Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.","has_exemption":false,"start_date":"2026-02-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"The Skin Center Dermatology Group","sponsor_slug":"the-skin-center-dermatology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07419373","publication_url":"https://clinicaltrials.gov/study/NCT07419373","title":"A Phase 2 Study to Evaluate Safety, Tolerability, And Virologic Efficacy of ARN-75039 For the Treatment of Lassa Fever in West Africa","has_exemption":false,"start_date":"2026-02-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Arisan Therapeutics, Inc.","sponsor_slug":"arisan-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07425015","publication_url":"https://clinicaltrials.gov/study/NCT07425015","title":"Ambulatory Long Length URodynamics Evaluation","has_exemption":false,"start_date":"2026-02-17","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Bright Uro","sponsor_slug":"bright-uro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07368959","publication_url":"https://clinicaltrials.gov/study/NCT07368959","title":"ASTRA: A Phase 3 Multi-center, Randomized, Double-Masked, Prospective Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-3)","has_exemption":false,"start_date":"2026-02-19","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Aurion Biotech","sponsor_slug":"aurion-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293715","publication_url":"https://clinicaltrials.gov/study/NCT07293715","title":"Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)","has_exemption":false,"start_date":"2026-02-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07328542","publication_url":"https://clinicaltrials.gov/study/NCT07328542","title":"A Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of Testosterone Cypionate Injection in Hypogonadal Men","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Azurity Pharmaceuticals","sponsor_slug":"azurity-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07441395","publication_url":"https://clinicaltrials.gov/study/NCT07441395","title":"A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Moderate to Severe Atopic Dermatitis (SIERRA1)","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Corvus Pharmaceuticals, Inc.","sponsor_slug":"corvus-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277582","publication_url":"https://clinicaltrials.gov/study/NCT07277582","title":"A Phase 2/3, Two-part, Dose-ranging, Adaptive Study to Evaluate Efficacy and Safety of THRV-1268 in Participants Diagnosed With Long QT Syndrome Type 2 (LQTS 2)","has_exemption":false,"start_date":"2026-03-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Thryv Therapeutics, Inc.","sponsor_slug":"thryv-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07672301","publication_url":"https://clinicaltrials.gov/study/NCT07672301","title":"Total Intravenous Anesthesia vs Spinal Anesthesia in Patients Undergoing Unilateral Primary Total Knee Arthroplasty","has_exemption":false,"start_date":"2026-03-11","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660186","publication_url":"https://clinicaltrials.gov/study/NCT06660186","title":"Randomized Trial of Rigid Plate Fixation Versus Wire Cerclage in High-Risk Sternotomy Patients","has_exemption":false,"start_date":"2026-03-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07363577","publication_url":"https://clinicaltrials.gov/study/NCT07363577","title":"A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Efficacy and Safety of LB 102 in the Treatment of Adult Patients With Acute Schizophrenia","has_exemption":false,"start_date":"2026-03-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"LB Pharmaceuticals Inc.","sponsor_slug":"lb-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513142","publication_url":"https://clinicaltrials.gov/study/NCT07513142","title":"A Single Blind, Randomized Controlled Trial Evaluating Platelet Poor Plasma Versus Corticosteroid Injections as A Control for Thigh Muscle Injuries","has_exemption":false,"start_date":"2026-03-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Andrews Research & Education Foundation","sponsor_slug":"andrews-research-education-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07502495","publication_url":"https://clinicaltrials.gov/study/NCT07502495","title":"A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets Despite Antihyperglycemic Medications","has_exemption":false,"start_date":"2026-03-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Biomea Fusion Inc.","sponsor_slug":"biomea-fusion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07159373","publication_url":"https://clinicaltrials.gov/study/NCT07159373","title":"Safety and Efficacy Trial of Mass Drug Administration With Moxidectin Versus Ivermectin in Combination With Diethylcarbamazine and Albendazole for Lymphatic Filariasis, Scabies, and Strongyloidiasis in Fiji","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Medicines Development for Global Health","sponsor_slug":"medicines-development-for-global-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184385","publication_url":"https://clinicaltrials.gov/study/NCT07184385","title":"A Multicenter, Double-blind, Randomized, Placebo-controlled, Two-arm Phase III Study to Assess the Efficacy of Human Umbilical Cord Blood (REGENECYTE) Infusion in Reducing Fatigue in Post-COVID Condition","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"StemCyte, Inc.","sponsor_slug":"stemcyte-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07485478","publication_url":"https://clinicaltrials.gov/study/NCT07485478","title":"Effects of the Invisalign® Palatal Expander (IPE) vs. Rapid Palatal Expander With Facemask in Growing Skeletal Class III Patients: A CBCT Randomized Clinical Trial","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Mahidol University","sponsor_slug":"mahidol-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07236190","publication_url":"https://clinicaltrials.gov/study/NCT07236190","title":"Early-phase Biomarker-based Trial of NPC-1 for Alzheimer's Disease Pathology","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07481370","publication_url":"https://clinicaltrials.gov/study/NCT07481370","title":"A Prospective Comparison of Isotretinoin and hCG Therapy in Males With Oligospermia and Azoospermia","has_exemption":false,"start_date":"2026-04-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07533006","publication_url":"https://clinicaltrials.gov/study/NCT07533006","title":"A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Proof of Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Severe Alopecia Areata","has_exemption":false,"start_date":"2026-04-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07081997","publication_url":"https://clinicaltrials.gov/study/NCT07081997","title":"A Phase 3, Multicenter, Randomized, Open-Label Trial Investigating the Safety, Tolerability and Efficacy of Palopegteriparatide Administered Subcutaneously Daily at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism","has_exemption":false,"start_date":"2026-04-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ascendis Pharma Bone Diseases A/S","sponsor_slug":"ascendis-pharma-bone-diseases-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447934","publication_url":"https://clinicaltrials.gov/study/NCT07447934","title":"Vibrotactile Stimulation for Lower Limb Spasticity","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07502508","publication_url":"https://clinicaltrials.gov/study/NCT07502508","title":"Phase 2 Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Not Achieving Glycemic Targets Despite GLP-1-Based Therapy","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Biomea Fusion Inc.","sponsor_slug":"biomea-fusion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07543367","publication_url":"https://clinicaltrials.gov/study/NCT07543367","title":"INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Synchron, Inc.","sponsor_slug":"synchron-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07559175","publication_url":"https://clinicaltrials.gov/study/NCT07559175","title":"A Phase 2a, Randomized, Open-Label, Active-Controlled, Crossover Study to Evaluate Safety and Explore Efficacy of Different Doses of New Lipase NHS7108 Administered Orally in Participants With Exocrine Pancreatic Insufficiency- EPIC","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Aimmune Nestlé Health Science US R&D, LLC","sponsor_slug":"aimmune-nestle-health-science-us-rd-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07483099","publication_url":"https://clinicaltrials.gov/study/NCT07483099","title":"A Phase 2, Multicenter, Randomized, Open-Label, Active-Controlled Study to Investigate LY4395089/Mirikizumab Co-administration Compared With Mirikizumab in Adults With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2026-05-04","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07483073","publication_url":"https://clinicaltrials.gov/study/NCT07483073","title":"A Master Protocol for Phase 2, Randomized, Controlled Studies of Multiple Interventions for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease","has_exemption":false,"start_date":"2026-05-04","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07268118","publication_url":"https://clinicaltrials.gov/study/NCT07268118","title":"Randomized Control Trial for Pain Control With Topical Lidocaine for Cervical Ripening Balloon Placement","has_exemption":false,"start_date":"2026-05-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07612644","publication_url":"https://clinicaltrials.gov/study/NCT07612644","title":"Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)","has_exemption":false,"start_date":"2026-05-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07615010","publication_url":"https://clinicaltrials.gov/study/NCT07615010","title":"Phase 2 Adaptive Randomized, Placebo -Controlled Trial of agenT-797 + Standard of Care Vs. Placebo + Standard of Care in Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure (AHRF) By Global ARDS Criteria","has_exemption":false,"start_date":"2026-05-26","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"MiNK Therapeutics","sponsor_slug":"mink-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07348601","publication_url":"https://clinicaltrials.gov/study/NCT07348601","title":"A Proof-of-Concept Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of CSTI-500 in Participants With Prader-Willi Syndrome","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"ConSynance Therapeutics","sponsor_slug":"consynance-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447206","publication_url":"https://clinicaltrials.gov/study/NCT07447206","title":"Vascular Intervention Strategies Trial for Alzheimer's (VISTA)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07536022","publication_url":"https://clinicaltrials.gov/study/NCT07536022","title":"Developing At-home taVNS for Neurorehabilitation in Parkinson's Disease","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07596030","publication_url":"https://clinicaltrials.gov/study/NCT07596030","title":"Feasibility of Self-Applied Vagus Nerve Stimulation for Chemotherapy Induced Peripheral Neuropathy","has_exemption":false,"start_date":"2026-06-02","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07460947","publication_url":"https://clinicaltrials.gov/study/NCT07460947","title":"A Pilot Trial of One Day Accelerated Intermittent Theta-burst Stimulation Plus D-cycloserine in Suicidal Patients With Borderline Personality Disorder (ONE-D BPD)","has_exemption":false,"start_date":"2026-06-09","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07336368","publication_url":"https://clinicaltrials.gov/study/NCT07336368","title":"Topical Cryotherapy to Reduce Pain During Steroid Injections for Keloid and Hypertrophic Scars: A Pilot Study","has_exemption":false,"start_date":"2026-06-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Sonal Choudhary","sponsor_slug":"sonal-choudhary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07625332","publication_url":"https://clinicaltrials.gov/study/NCT07625332","title":"Pilot Study of Tolerability and Preliminary Efficacy of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)","has_exemption":false,"start_date":"2026-06-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05470478","publication_url":"https://clinicaltrials.gov/study/NCT05470478","title":"Enhancement and Optimization of a Mobile iBCI for Veterans With Paralysis","has_exemption":false,"start_date":"2026-06-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07644559","publication_url":"https://clinicaltrials.gov/study/NCT07644559","title":"A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and With Cetuximab, in Patients With Metastatic KRAS G12D-Mutated Pancreatic Cancer (TARGET-D 201)","has_exemption":false,"start_date":"2026-06-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Verastem, Inc.","sponsor_slug":"verastem-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05279937","publication_url":"https://clinicaltrials.gov/study/NCT05279937","title":"The Use of Ultrasound-Guided Dextrose Prolotherapy in Low Back Pain in Patients With Hypermobile-Type, Ehlers-Danlos Syndrome","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Tulane University","sponsor_slug":"tulane-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660017","publication_url":"https://clinicaltrials.gov/study/NCT06660017","title":"Ketamine Oral Rinse in the Management of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518941","publication_url":"https://clinicaltrials.gov/study/NCT06518941","title":"An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06880562","publication_url":"https://clinicaltrials.gov/study/NCT06880562","title":"Renal and Splanchnic Sympathetic Denervation as an Alternative Therapy for Resistant Hypertension and Type 2 Diabetes (RESPLASH Study)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Tulane University","sponsor_slug":"tulane-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06884176","publication_url":"https://clinicaltrials.gov/study/NCT06884176","title":"Complication Rates Associated With Central Venous Catheters Versus Midline Catheters: A Randomized Control Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959082","publication_url":"https://clinicaltrials.gov/study/NCT06959082","title":"A Multi-center, Randomized, Open-label, Parallel-group, Phase 2 Study to Evaluate the Efficacy and Safety of VS-101 in Combination With Chemoradiotherapy (CRT) in Patients With Head and Neck Cancer","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"VSPharmTech Co.,Ltd.","sponsor_slug":"vspharmtech-coltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06966492","publication_url":"https://clinicaltrials.gov/study/NCT06966492","title":"Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215481","publication_url":"https://clinicaltrials.gov/study/NCT07215481","title":"Quantitative Digitography to Evaluate the Efficacy of Image Guided Algorithmic DBS Programming","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07185945","publication_url":"https://clinicaltrials.gov/study/NCT07185945","title":"Phase II Trial of Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Guru Sonpavde","sponsor_slug":"guru-sonpavde","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321860","publication_url":"https://clinicaltrials.gov/study/NCT07321860","title":"Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Partial TGF-βR1 (ALK5) Inhibition With Galunisertib Combined With PDE4 Inhibition With Nerandomilast in GREM2-Positive ALS","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Gipfel Life Sciences GmbH","sponsor_slug":"gipfel-life-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07322133","publication_url":"https://clinicaltrials.gov/study/NCT07322133","title":"Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension: A Pilot Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424183","publication_url":"https://clinicaltrials.gov/study/NCT07424183","title":"T4/T3 Therapy in Hypothyroidism","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07461506","publication_url":"https://clinicaltrials.gov/study/NCT07461506","title":"Mitigating Opioid Use Disorder Risk With Enhanced Opioid Sparing Pain Relief for Wisdom Teeth Extractions With a Novel Nanotechnology","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"nCap Medical","sponsor_slug":"ncap-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07473128","publication_url":"https://clinicaltrials.gov/study/NCT07473128","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre Trial Comparing Efficacy and Safety of Trilaciclib Versus Placebo in Participants With Limited-stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Pharmacosmos A/S","sponsor_slug":"pharmacosmos-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07478055","publication_url":"https://clinicaltrials.gov/study/NCT07478055","title":"Biomarkers in Management of PP Preeclampsia","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Alexander Harrison","sponsor_slug":"alexander-harrison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07494838","publication_url":"https://clinicaltrials.gov/study/NCT07494838","title":"IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Lucas R. Cusumano, MD","sponsor_slug":"lucas-r-cusumano-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07518901","publication_url":"https://clinicaltrials.gov/study/NCT07518901","title":"Ferumoxytol Nanozymes for Biofilm Disruption: A Clinical Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523581","publication_url":"https://clinicaltrials.gov/study/NCT07523581","title":"A Randomized, Double-Blind, Placebo-Controlled, Delayed-Start Study to Evaluate the Efficacy and Safety of Exaluren in Alport Syndrome Patients With Nonsense Mutations in COL4A3/4/5 Genes","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eloxx Pharmaceuticals, Inc.","sponsor_slug":"eloxx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07540897","publication_url":"https://clinicaltrials.gov/study/NCT07540897","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 Study 304)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Alkermes, Inc.","sponsor_slug":"alkermes-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07572591","publication_url":"https://clinicaltrials.gov/study/NCT07572591","title":"Assessment of Wearable Ultrasound for Modulation","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07582211","publication_url":"https://clinicaltrials.gov/study/NCT07582211","title":"Bilevel Positive Airway Pressure (BPAP) for Severe Asthma Exacerbations: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07580404","publication_url":"https://clinicaltrials.gov/study/NCT07580404","title":"The Utility of Emsella for Reducing Transient Stress Urinary Incontinence (tSUI) Following Holmium Laser Enucleation of the Prostate (HoLEP)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07590518","publication_url":"https://clinicaltrials.gov/study/NCT07590518","title":"AI-Enhanced Virtual Reality Cognitive Behavioral Therapy to Reduce Anxiety and Improve Quality of Life in Patients With Inflammatory Bowel Disease: A Multicenter Pilot and Feasibility Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Brennan Spiegel","sponsor_slug":"brennan-spiegel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07599826","publication_url":"https://clinicaltrials.gov/study/NCT07599826","title":"Active vs. Passive Virtual Reality for Reducing Pain and Anxiety During Office-based ENT Procedures","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07610746","publication_url":"https://clinicaltrials.gov/study/NCT07610746","title":"Early Detection of Neonatal Opioid Withdrawal Syndrome Using a Novel Cerebral Monitor.","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07613658","publication_url":"https://clinicaltrials.gov/study/NCT07613658","title":"3D-Printed Custom Versus Conventional Band-and-Loop Versus Chairside Denovo Space Maintainers in the Primary Dentition: A Randomized Controlled Trial Protocol","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Murad Alrashidi","sponsor_slug":"murad-alrashidi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07625293","publication_url":"https://clinicaltrials.gov/study/NCT07625293","title":"A Phase 2a Study of DB-3Q for the Treatment of Medically Refractory Crohn's Disease","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Direct Biologics, LLC","sponsor_slug":"direct-biologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07632742","publication_url":"https://clinicaltrials.gov/study/NCT07632742","title":"MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07659782","publication_url":"https://clinicaltrials.gov/study/NCT07659782","title":"A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients With Previously Treated, Advanced KRAS G12D-Mutated Non-Small Cell Lung Cancer (TARGET-D 202)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Verastem, Inc.","sponsor_slug":"verastem-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07667569","publication_url":"https://clinicaltrials.gov/study/NCT07667569","title":"A Phase 2a, Proof of Concept, Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial to Assess the Efficacy and Safety of ACT-777991 in Adults With Non-segmental Vitiligo","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Idorsia Pharmaceuticals Ltd.","sponsor_slug":"idorsia-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07686913","publication_url":"https://clinicaltrials.gov/study/NCT07686913","title":"A Randomized Prospective Trial Comparing Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Riverside University Health System Medical Center","sponsor_slug":"riverside-university-health-system-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07709741","publication_url":"https://clinicaltrials.gov/study/NCT07709741","title":"Sustained Release Oral Formulation For Treatment Of Parkinsons Disease","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06327373","publication_url":"https://clinicaltrials.gov/study/NCT06327373","title":"A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06818981","publication_url":"https://clinicaltrials.gov/study/NCT06818981","title":"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Post-Operative Steroids After Sleep Surgery","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07339215","publication_url":"https://clinicaltrials.gov/study/NCT07339215","title":"A Prospective Randomized Trial of Local Antibiotic Carriers in Tissue Expander-Based Breast Reconstruction","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07557121","publication_url":"https://clinicaltrials.gov/study/NCT07557121","title":"A Phase 2, Multicenter, Randomized, Active-controlled Trial of the Safety and Efficacy of AIV007 by Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Aiviva BioPharma Inc.","sponsor_slug":"aiviva-biopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07672015","publication_url":"https://clinicaltrials.gov/study/NCT07672015","title":"Precision Pain Management - A Randomized Clinical Trial Assessing the Efficacy of Suzetrigine on Postoperative Analgesia Among Surgical Patients at Higher Risk for Persistent Postoperative Opioid Use (POU)","has_exemption":false,"start_date":"2026-07-02","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07048314","publication_url":"https://clinicaltrials.gov/study/NCT07048314","title":"A Randomized Clinical Trial to Assess Safety and Efficacy of Allogeneic Adipose-derived Mesenchymal Stem Cells in Promoting the Recovery of Erectile Function Post Radical Retropubic Prostatectomy of Localized Prostate Cancer","has_exemption":false,"start_date":"2026-07-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06557733","publication_url":"https://clinicaltrials.gov/study/NCT06557733","title":"Phase 2 Study to Evaluate the Efficacy and Safety of TPST-1495 in Patients With Familial Adenomatous Polyposis (FAP)","has_exemption":false,"start_date":"2026-07-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07595302","publication_url":"https://clinicaltrials.gov/study/NCT07595302","title":"Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain: A Randomized, Double-Blind, Double-Dummy Controlled Trial (PIVOTAL Trial)","has_exemption":false,"start_date":"2026-07-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06806332","publication_url":"https://clinicaltrials.gov/study/NCT06806332","title":"Glaucoma Drop Aids Part 2","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07038889","publication_url":"https://clinicaltrials.gov/study/NCT07038889","title":"Investigating the Feasibility and Translational Therapeutic Benefits of Overground, Fully Immersive Virtual Reality (VR) Gait Rehabilitation Therapies for Individuals With Traumatic Brain Injury (TBI)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null}]}